Table 2.
Characteristic | HR (95%CI) | P |
---|---|---|
Gender | ||
Male | Reference | .647 |
Female | 0.976 (0.881–1.082) | |
Age | ||
18–40 | Reference | .000 |
40–60 | 2.185 (1.528–3.124) | .021 |
60–80 | 4.333 (3.052–6.153) | .010 |
80- | 7.714 (5.326–11.172) | .000 |
Race | ||
White | Reference | .113 |
Black | 1.010 (0.808–1.262) | |
Asian or pacific islander | 0.737 (0.552–0.982) | |
Grade | ||
Grade 1–2 | Reference | .000 |
Grade 3–4 | 15.151 (8.928–25.713) | |
Laterality | ||
Left - origin of primary | Reference | .001 |
Right - origin of primary | 1.018 (0.887–1.169) | .080 |
Bilateral | 1.533 (0.943–2.491) | .059 |
Not a paired site | 1.227 (1.086–1.387) | .125 |
Surgery | ||
No | Reference | .000 |
Yes | 0.494 (0.437–0.559) | |
Radiation | ||
No | Reference | .000 |
Yes | 0.472 (0.422–0.528) | |
Chemotherapy recode | ||
No | Reference | .000 |
Yes | 0.501 (0.453–0.555) | |
Year at diagnosis | ||
1975–1985 | Reference | .499 |
1985–1995 | 0.824 (0.552–1.230) | .073 |
1995–2005 | 0.948 (0.652–1.379) | .354 |
2005–2016 | 0.931 (0.643–1.348) | .200 |
HR = hazard ratio.